I have mild COVID – should I take the antiviral Paxlovid?

  • Mark Morgan
  • Amanda Gwee
  • Jason Roberts
  • Nicole Allard
  • Tari Turner

Press/Media: Expert Comment

Description

The COVID medication Paxlovid has been available in Australia on the Pharmaceuticals Benefits Scheme (PBS) since the start of May, with eligible patients directed to talk to their GP for a prescription.

Paxlovid is an oral treatment for mild COVID, taken as a tablet, which has two active ingredients: nirmatrelvir and ritonavir. Together, they reduce the ability of SARS-CoV-2, the virus that causes COVID, to multiply in your body.

Subject

COVID-19

Antiviral

Living Guidelines

Period27 May 2022

Media contributions

1

Media contributions

  • TitleI have mild COVID – should I take the antiviral Paxlovid?
    Media name/outletThe Conversation
    Media typeWeb
    Country/TerritoryAustralia
    Date27/05/22
    DescriptionThe COVID medication Paxlovid has been available in Australia on the Pharmaceuticals Benefits Scheme (PBS) since the start of May, with eligible patients directed to talk to their GP for a prescription.

    Paxlovid is an oral treatment for mild COVID, taken as a tablet, which has two active ingredients: nirmatrelvir and ritonavir. Together, they reduce the ability of SARS-CoV-2, the virus that causes COVID, to multiply in your body.
    URLhttps://theconversation.com/i-have-mild-covid-should-i-take-the-antiviral-paxlovid-183913
    PersonsMark Morgan, Amanda Gwee, Jason Roberts, Nicole Allard, Tari Turner
View all 1
View less